jak inhibitors from selleck

1
Inhibitors of JAK/STAT Pathway file:///E|/work/e-marketing/newsletter/2011.10.30_Product-JAK-STAT-Inhibitor/Product-JAK-STAT-Inhibitor.html[2012/2/8 17:55:08] Unable to read? View web version . | Inhibitor | Antibody | siRNA | Peptide | Free Sample Program Scientific Reviews Coupons Catalog Download Dear customer, Based on your research area, Selleck has special recommendations for you on our inhibitors of JAK / STAT pathway currently targeting JAK. Cat. No. Inhibitor Name Purity S2162 AZD1480 >99% Bioactivity: AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM. S2179 LY2784544 >99% Bioactivity: LY2784544 is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM. S2686 NVP-BSK805 >99% Bioactivity: NVP-BSK805 is a potent and selective quinoxaline JAK2 inhibitor with IC50 of 0.48, 0.56 and 0.58 nM for JAK2 JH1, FL JAK V617F and FL JAK2 wt, respectively. Applications & Feedbacks AZD1480 <More> LY2784544 <More> Papers Using Selleck Inhibitors AZD1480 Deshpande A, et al. Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia . 2011 Sep 16. doi: 10.1038/leu.2011.255. More Inhibitors Targeting JAK AG-490 AT9283 AZ 960 CP-690550 (Tasocitinib) Cyt387 INCB018424 (Ruxolitinib) TG101209 More Inhibitors of the JAK / STAT Pathway by Target STAT More Inhibitors of Selleck Signal Pathways by Pathway Apoptosis Cell Cycle / Checkpoint Ion Channel TGF-beta / Smad by Research Area Cancer Immunology Inflammation Metabolic Disease Follow us: Tel: +1-713-922-4115 Fax: +1-713-796-9816 Email: [email protected] Address: 2626 South Loop West, Suite 225, Houston, TX 77054 USA. Tel: +49-89-829693-77 Fax: +49-89-829693-78 Email: [email protected] Address: Karl-Schmid-Str. 14 81829 Munich, Germany.

Upload: selleck-chemicals-llc

Post on 21-Apr-2015

84 views

Category:

Documents


0 download

DESCRIPTION

jak inhibitors, jak2 inhibitor, jak1 inhibitor, jak3 inhibitor

TRANSCRIPT

Page 1: JAK Inhibitors From Selleck

Inhibitors of JAK/STAT Pathway

file:///E|/work/e-marketing/newsletter/2011.10.30_Product-JAK-STAT-Inhibitor/Product-JAK-STAT-Inhibitor.html[2012/2/8 17:55:08]

Unable to read? View web version.

| Inhibitor | Antibody | siRNA | Peptide |Free Sample

ProgramScientificReviews

Coupons CatalogDownload

Dear customer,

Based on your research area, Selleck has special recommendations for you on our inhibitors of JAK /STAT pathway currently targeting JAK.

Cat. No. Inhibitor Name Purity

S2162 AZD1480 >99%

Bioactivity: AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of0.26 nM.

S2179 LY2784544 >99%

Bioactivity: LY2784544 is a small molecule selective mutant JAK2 kinaseinhibitor with an IC50 of 68 nM.

S2686 NVP-BSK805 >99%

Bioactivity: NVP-BSK805 is a potent and selective quinoxaline JAK2inhibitor with IC50 of 0.48, 0.56 and 0.58 nM for JAK2 JH1, FL JAK V617Fand FL JAK2 wt, respectively.

Applications & Feedbacks

AZD1480 <More> LY2784544 <More>

Papers Using Selleck Inhibitors

AZD1480

Deshpande A, et al. Kinase domain mutations confer resistance to novelinhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia.2011 Sep 16. doi: 10.1038/leu.2011.255.

More Inhibitors TargetingJAK

AG-490 AT9283

AZ 960CP-690550(Tasocitinib)

Cyt387INCB018424(Ruxolitinib)

TG101209

More Inhibitors of the JAK/ STAT Pathway

by Target

STAT

More Inhibitors of SelleckSignal Pathways

by Pathway

Apoptosis

Cell Cycle / Checkpoint

Ion Channel

TGF-beta / Smad

by Research Area

Cancer

Immunology

Inflammation

Metabolic Disease

Follow us:

Tel: +1-713-922-4115Fax: +1-713-796-9816Email: [email protected] Address: 2626 South Loop West, Suite 225,Houston, TX 77054 USA.

Tel: +49-89-829693-77Fax: +49-89-829693-78Email: [email protected]: Karl-Schmid-Str. 14 81829 Munich,Germany.